A detailed history of Ikarian Capital, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 466,019 shares of MIST stock, worth $862,135. This represents 0.12% of its overall portfolio holdings.

Number of Shares
466,019
Previous 466,019 -0.0%
Holding current value
$862,135
Previous $615,000 15.12%
% of portfolio
0.12%
Previous 0.25%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.4 - $2.2 $4,467 - $7,020
3,191 Added 0.69%
466,019 $834,000
Q3 2023

Nov 14, 2023

BUY
$2.68 - $3.69 $6,464 - $8,900
2,412 Added 0.52%
462,828 $1.43 Million
Q4 2022

Feb 14, 2023

SELL
$3.53 - $9.5 $1.4 Million - $3.75 Million
-395,200 Reduced 46.19%
460,416 $1.82 Million
Q3 2022

Nov 14, 2022

SELL
$5.86 - $9.43 $3.07 Million - $4.94 Million
-523,806 Reduced 37.97%
855,616 $7.86 Million
Q2 2022

Aug 12, 2022

SELL
$5.13 - $7.37 $2.82 Million - $4.05 Million
-549,330 Reduced 28.48%
1,379,422 $8.19 Million
Q1 2022

May 13, 2022

BUY
$4.1 - $8.24 $732,706 - $1.47 Million
178,709 Added 10.21%
1,928,752 $12.4 Million
Q3 2021

Nov 15, 2021

SELL
$5.28 - $6.29 $1.22 Million - $1.45 Million
-230,357 Reduced 11.63%
1,750,043 $9.99 Million
Q2 2021

Aug 16, 2021

BUY
$5.22 - $6.11 $750,923 - $878,954
143,855 Added 7.83%
1,980,400 $10.9 Million
Q4 2020

Feb 12, 2021

BUY
$5.57 - $7.66 $518,010 - $712,380
93,000 Added 5.33%
1,836,545 $12.3 Million
Q3 2020

Nov 16, 2020

BUY
$3.34 - $9.8 $5.82 Million - $17.1 Million
1,743,545 New
1,743,545 $12.8 Million

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.5M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.